JACKSAM CORPORATION - JKSM STOCK NEWS

Jacksam Corporation (OTCQB:JKSM) announced its financial results for Q1 2022, reporting revenue of $1.8 million, unchanged from the previous year. Cartridge sales surged 662% to $0.7 million, while overall gross profit declined by 19% to $0.4 million. Operating expenses improved, decreasing to 23% of revenue. Net income rose significantly to $29,384 from a loss in 2021. The company also strengthened its cash position to $0.8 million. Strategic partnership with Emerald Scientific aims to boost distribution in the cannabis sector.

Jacksam Corporation dba Convectium (OTCQB: JKSM) has announced an exclusive distribution agreement with Emerald Scientific, LLC, aimed at enhancing sales of its cannabis and CBD automation products. This partnership allows Emerald Scientific to distribute Convectium's vape filling and capping equipment, leveraging their sales expertise in the cannabis sector. The collaboration is positioned to improve market penetration for Convectium's products. Convectium's equipment promises significant production efficiency, with output increases of up to 60 times compared to manual filling.

Jacksam Corporation, operating as Convectium (OTCQB: JKSM), reported robust financial results for Q3 2021, showcasing $1.95M in sales, a 165% increase year-over-year and a 17% increase quarter-over-quarter. Their strategy of recurring orders and diversification into the flower market contributed to a 100bps expansion in gross margin and EBITDA profitability. The company successfully secured its first multi-million-dollar recurring revenue order and launched a new automated pre-roll infusion machine at MJBizCon in Las Vegas.

Jacksam Corporation, operating as Convectium (OTCQB: JKSM), has launched the Convectium IFX-100, its first automated pre-roll infusion machine, designed to meet the growing demand for infused pre-rolls in the cannabis industry. Utilizing a patent-pending technology, the IFX-100 can infuse up to 6,000 pre-rolls per hour with precise dosing ranging from 50mg to 500mg. The popularity of infused pre-rolls has surged, comprising 45% of California's pre-roll sales as of July 2021. This automation is expected to transform production efficiency for cannabis producers.

Jacksam Corporation, operating as Convectium (OTCQB: JKSM), reported its Q2 2021 financial results, showcasing significant growth in sales. The Company achieved $1.66M in sales, up 162% year-over-year, despite a 6% quarter-over-quarter decline due to delayed deliveries of its 'PreRoll-ER' machines. Core product sales, particularly filling and capping machines, increased 25% from the previous quarter. Operating expenses were affected by a one-time $219,606 insurance payment. CEO Mark Adams expressed optimism for future growth, especially with the upcoming MJBizCon event.

Jacksam Corporation, operating as Convectium (OTCQB: JKSM), announced a commitment for up to $1.5 million in common stock and warrants from Triton Funds LP. This investment is intended to enhance Convectium's market penetration within the cannabis and CBD sector. Notably, the company achieved its first operating profit. CEO Mark Adams highlighted the funding's role in expanding sales and engineering capabilities in newly legalized states, along with developing next-generation automation solutions.

Jacksam Corporation, operating as Convectium (OTCQB: JKSM), reported robust 1st quarter sales of $1.78M, marking a 171% increase year-over-year and a 40% rise from Q4 2020. This growth is attributed to the launch of new products, notably the 'Pre Roll-ER', and sustained demand for their core filling and capping equipment. For the first time, the company also achieved operating profitability. CEO Mark Adams noted that the restructuring strategy initiated in 2020 greatly contributed to these results, while Executive Chairman Scott Wessler highlighted the firm’s readiness to leverage market momentum.